Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP Monica Raines sold 219 shares of the company’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $23,073.84. Following the transaction, the executive vice president directly owned 13,801 shares in the company, valued at approximately $1,454,073.36. This represents a 1.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Monica Raines also recently made the following trade(s):
- On Tuesday, February 24th, Monica Raines sold 437 shares of Addus HomeCare stock. The shares were sold at an average price of $106.99, for a total value of $46,754.63.
Addus HomeCare Trading Down 3.3%
ADUS stock traded down $3.58 during midday trading on Thursday, reaching $104.02. The stock had a trading volume of 269,378 shares, compared to its average volume of 239,147. The firm has a market cap of $1.92 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 1.26 and a beta of 0.91. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $124.43. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The business has a fifty day simple moving average of $109.57 and a two-hundred day simple moving average of $113.08.
Institutional Trading of Addus HomeCare
Addus HomeCare News Roundup
Here are the key news stories impacting Addus HomeCare this week:
- Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
- Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
- Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
- Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
- Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
- Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data
Wall Street Analyst Weigh In
Several brokerages recently weighed in on ADUS. BMO Capital Markets initiated coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price objective on the stock. KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Stephens decreased their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday. Finally, Barclays dropped their price objective on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $134.33.
Read Our Latest Stock Analysis on Addus HomeCare
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- Unlocked: Elon Musk’s Next Big IPO
- REVEALED: Something Big Happening Behind White House Doors
- This makes me furious
- The free stock picks nobody’s talking about
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
